253 related articles for article (PubMed ID: 21735853)
1. [Cost of lost productivity in pharmacoeconomics analysis. Part II. Survey in the expert group].
Wrona W; Hermanowski T; Jakubczyk M; Golicki D; Czech M; Niewada M; Kolasa K
Przegl Epidemiol; 2011; 65(1):153-7. PubMed ID: 21735853
[TBL] [Abstract][Full Text] [Related]
2. [Cost of lost productivity in pharmacoeconomics analysis. Part I. A systematic review of the literature].
Wrona W; Hermanowski T; Golicki D; Jakubczyk M; Macioch T; Goszczyńska K; Wójcik R
Przegl Epidemiol; 2011; 65(1):147-52. PubMed ID: 21735852
[TBL] [Abstract][Full Text] [Related]
3. [Indirect costs in health technology assessment].
Jakubczyk M; Wrona W; Macioch T; Golicki D; Niewada M; Hermanowski T
Pol Merkur Lekarski; 2010 Jan; 28(163):42-5. PubMed ID: 20369723
[TBL] [Abstract][Full Text] [Related]
4. The transferability of valuing lost productivity across jurisdictions. differences between national pharmacoeconomic guidelines.
Knies S; Severens JL; Ament AJ; Evers SM
Value Health; 2010 Aug; 13(5):519-27. PubMed ID: 20712601
[TBL] [Abstract][Full Text] [Related]
5. Economic cost of Guillain-Barré syndrome in the United States.
Frenzen PD
Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
[TBL] [Abstract][Full Text] [Related]
6. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.
Merkesdal S; Ruof J; Huelsemann JL; Mittendorf T; Handelmann S; Mau W; Zeidler H
Arthritis Rheum; 2005 Apr; 53(2):234-40. PubMed ID: 15818718
[TBL] [Abstract][Full Text] [Related]
7. The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work.
Li X; Gignac MA; Anis AH
Med Care; 2006 Apr; 44(4):304-10. PubMed ID: 16565630
[TBL] [Abstract][Full Text] [Related]
8. Workplace smoking related absenteeism and productivity costs in Taiwan.
Tsai SP; Wen CP; Hu SC; Cheng TY; Huang SJ
Tob Control; 2005 Jun; 14 Suppl 1(Suppl 1):i33-7. PubMed ID: 15923446
[TBL] [Abstract][Full Text] [Related]
9. Costs and quality of life of multiple sclerosis in Austria.
Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
[TBL] [Abstract][Full Text] [Related]
10. Indirect cost of ischemic heart disease to employers.
Guico-Pabia CJ; Murray JF; Teutsch SM; Wertheimer AI; Berger ML
Am J Manag Care; 2001 Jan; 7(1):27-34. PubMed ID: 11209448
[TBL] [Abstract][Full Text] [Related]
11. The burden of illness associated with renal cell carcinoma in the United States.
Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
[TBL] [Abstract][Full Text] [Related]
12. Correcting for compensating mechanisms related to productivity costs in economic evaluations of health care programmes.
Jacob-Tacken KH; Koopmanschap MA; Meerding WJ; Severens JL
Health Econ; 2005 May; 14(5):435-43. PubMed ID: 15497201
[TBL] [Abstract][Full Text] [Related]
13. Costs and quality of life for patients with multiple sclerosis in Belgium.
Kobelt G
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
[TBL] [Abstract][Full Text] [Related]
14. How do Italian pharmacoeconomists evaluate indirect costs?
Garattini L; Tediosi F; Ghislandi S; Orzella L; Rossi C
Value Health; 2000; 3(4):270-6. PubMed ID: 16464191
[TBL] [Abstract][Full Text] [Related]
15. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
16. Costs and quality of life of multiple sclerosis in Switzerland.
Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
[TBL] [Abstract][Full Text] [Related]
17. Indirect costs and incidence of caregivers' short-term absenteeism in Poland, 2006-2016.
Łyszczarz B
BMC Public Health; 2019 May; 19(1):598. PubMed ID: 31101035
[TBL] [Abstract][Full Text] [Related]
18. [Cost measurement based on a cost diary in patients with inflammatory bowel disease].
Rösch M; Leidl R; Tirpitz Cv; Reinshagen M; Adler G; König HH
Z Gastroenterol; 2002 Apr; 40(4):217-28. PubMed ID: 11961730
[TBL] [Abstract][Full Text] [Related]
19. Costs and quality of life of multiple sclerosis in Italy.
Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
[TBL] [Abstract][Full Text] [Related]
20. Cost of cardiovascular diseases in the United Kingdom.
Luengo-Fernández R; Leal J; Gray A; Petersen S; Rayner M
Heart; 2006 Oct; 92(10):1384-9. PubMed ID: 16702172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]